PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
February 3, 2011 | ISSUE NUMBER 185 VOL 8

People
Pfizer CMO Named Woman of the Year
Freda Lewis-Hall, Pfizer’s Chief Medical Officer, has been named 2011 Woman of the Year by the Healthcare Businesswomen’s Association.

Biotechnology
California Biotech: Good Governance Tops Wish List
New industry survey data documents a fraying investment base marked by a distant and unresponsive FDA as well as an unprepared workforce complacent about hungry foreign competition.

Regulatory
New Opportunity in the Absence of Avastin
In July 2010, FDA was urged to withdraw the use of Avastin in metastatic HER2-negative breast cancer. Since then, it has been dropped across all lines of therapy—but for other products in the breast cancer market, this does not necessarily open the door for new therapies.

Oncology
Fighting Cancer—A Checklist for Change
Payer and regulatory pressures are likely to take some steam off of heady projections of market growth in this sensitive therapeutic area.

// Amarin Corp. (Mystic, Conn., and Dublin, Ireland), a clinical-stage biopharmaceutical company, announced that Paul E. Huff has joined the company as Chief Commercial Officer. // Lannett Co. (Philadelphia), a specialty pharmaceutical company, announced the promotion of William F. Schreck to Chief Operating Officer. // Qforma (Sante Fe, NM, and Princeton, NJ), a provider of advanced analytics and predictive modelling technologies, announced the appointments of Ted Pine and Devon Reimer as Vice Presidents of Business Development, and Michael Murphy as Software Engineer. // Susan Schniepp, Vice President of Quality at OSO BioPharmaceuticals Manufacturing (Albuquerque, NM), has been elected to the Board of Directors at the Parenteral Drug Association (Bethesda, MD).

March 22-23: iPharma Connect—Digitally Connecting with Patients, Physicians, and Payers
Philadelphia, PA


April 8-10: Asian Oncology Summit 2011
Hong Kong


May 5: Healthcare Businesswomen’s Association Woman of the Year
Fairfield, NJ


CBI’s 12th Annual Patient Assistance and Access Programs
Assess the Impact of Reform and Discover New Models for Ensuring Assistance, Advocacy, Continuity of Care and Access for Your Patients
March 1 – 2, 2011
Baltimore, MD
www.cbinet.com/PAP
 
CBI's 2nd Annual Risk Sharing and Innovative Contracting Models
Evaluate Outcomes-Based Agreements - Apply Value-Based Pricing - Achieve Preferred Status - Gain Competitive Advantage
March 24-25, 2011
Join all key stakeholders for a high-touch update on the future of contracting and hear measurable results about agreements that have actually been implemented in the United States. Learn how to best apply these contracts to optimize success. www.cbinet.com/risksharing
 
Patient Behavior Doesn't Start or End with an Rx
Learn more about the dynamics of your market, including patient and prescriber behavior, by combining information about patient activities as they travel through their Continuum of CareTM. Monitor patients as they fill prescriptions, visit their physician, receive lab test results, go to the hospital, and make retail purchases. Click here to find out what you're missing.

 
FindPharma  
Search  

Survey
What should pharma’s relationship with patients be?
Click To Vote
 
 
Quick Links

New Pharm Exec Global Digest—Available Now

Pfizer Closure "Shocking Wake-Up Call" for UK

Innovators: Take a Note from the Generics Industry’s Books


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive